Search research articles
Contact Us
Filters
Showing results (71-80 of 112) with videos related to
Page
of 12
Sort By:
Kidney International
|
October 4, 2013
The Nrf2 triterpenoid activator, CDDO-imidazolide, protects kidneys from ischemia-reperfusion injury in mice
Manchang Liu, Narsa M Reddy, Elizabeth M Higbee, et al.
Journal of Medicinal Chemistry
|
September 17, 2004
Design, synthesis, and biological evaluation of biotin conjugates of 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid for the isolation of the protein targets
Tadashi Honda, Tomasz Janosik, Yukiko Honda, et al.
Cancer Research
|
March 17, 2007
The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A/J mice
Karen Liby, Darlene B Royce, Charlotte R Williams, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 26, 2006
Design, synthesis, and anti-inflammatory activity both in vitro and in vivo of new betulinic acid analogues having an enone functionality in ring A
Tadashi Honda, Karen T Liby, Xiaobo Su, et al.
Molecular Oncology
|
May 7, 2023
The synthetic oleanane triterpenoid CDDO-2P-Im binds GRP78/BiP to induce unfolded protein response-mediated apoptosis in myeloma
George Luo, Kristin Aldridge, Toby Chen, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
March 26, 2014
Complete protection against aflatoxin B(1)-induced liver cancer with a triterpenoid: DNA adduct dosimetry, molecular signature, and genotoxicity threshold
Natalie M Johnson, Patricia A Egner, Victoria K Baxter, et al.
Cancer Research
|
June 3, 2005
Synthetic triterpenoids cooperate with tumor necrosis factor-related apoptosis-inducing ligand to induce apoptosis of breast cancer cells
Marc L Hyer, Rhonda Croxton, Maryla Krajewska, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 11, 2002
Prevention and treatment of experimental breast cancer with the combination of a new selective estrogen receptor modulator, arzoxifene, and a new rexinoid, LG 100268
Nanjoo Suh, William W Lamph, Andrew L Glasebrook, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 15, 2009
The triterpenoid CDDO-imidazolide confers potent protection against hyperoxic acute lung injury in mice
Narsa M Reddy, Vegiraju Suryanaraya, Melinda S Yates, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
July 17, 2013
Oral administration of a gemini vitamin D analog, a synthetic triterpenoid and the combination prevents mammary tumorigenesis driven by ErbB2 overexpression
Jae Young So, Joseph E Wahler, Taesook Yoon, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 112) with videos related to
Sort By:
Page
of 12
Kidney International
|
October 4, 2013
The Nrf2 triterpenoid activator, CDDO-imidazolide, protects kidneys from ischemia-reperfusion injury in mice
Manchang Liu, Narsa M Reddy, Elizabeth M Higbee, et al.
Journal of Medicinal Chemistry
|
September 17, 2004
Design, synthesis, and biological evaluation of biotin conjugates of 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid for the isolation of the protein targets
Tadashi Honda, Tomasz Janosik, Yukiko Honda, et al.
Cancer Research
|
March 17, 2007
The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A/J mice
Karen Liby, Darlene B Royce, Charlotte R Williams, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 26, 2006
Design, synthesis, and anti-inflammatory activity both in vitro and in vivo of new betulinic acid analogues having an enone functionality in ring A
Tadashi Honda, Karen T Liby, Xiaobo Su, et al.
Molecular Oncology
|
May 7, 2023
The synthetic oleanane triterpenoid CDDO-2P-Im binds GRP78/BiP to induce unfolded protein response-mediated apoptosis in myeloma
George Luo, Kristin Aldridge, Toby Chen, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
March 26, 2014
Complete protection against aflatoxin B(1)-induced liver cancer with a triterpenoid: DNA adduct dosimetry, molecular signature, and genotoxicity threshold
Natalie M Johnson, Patricia A Egner, Victoria K Baxter, et al.
Cancer Research
|
June 3, 2005
Synthetic triterpenoids cooperate with tumor necrosis factor-related apoptosis-inducing ligand to induce apoptosis of breast cancer cells
Marc L Hyer, Rhonda Croxton, Maryla Krajewska, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 11, 2002
Prevention and treatment of experimental breast cancer with the combination of a new selective estrogen receptor modulator, arzoxifene, and a new rexinoid, LG 100268
Nanjoo Suh, William W Lamph, Andrew L Glasebrook, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 15, 2009
The triterpenoid CDDO-imidazolide confers potent protection against hyperoxic acute lung injury in mice
Narsa M Reddy, Vegiraju Suryanaraya, Melinda S Yates, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
July 17, 2013
Oral administration of a gemini vitamin D analog, a synthetic triterpenoid and the combination prevents mammary tumorigenesis driven by ErbB2 overexpression
Jae Young So, Joseph E Wahler, Taesook Yoon, et al.
Page
of 12